Makoto Hirotani

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Sonoko Misawa, Satoshi Kuwabara, Yasunori Sato et al. · The Lancet Neurology · 2018 · 159 citations

Medicine, Neurology, Guillain-barré Syndrome +1

Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis

Ikuko Takahashi, Yuka Hama, Masaaki Matsushima et al. · Molecular Brain · 2015 · 118 citations · Full text

Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan

Hideki Houzen, Masaaki Niino, Makoto Hirotani et al. · Journal of the Neurological Sciences · 2012 · 101 citations

Neurological Disorder, Neuroepidemiology, Northern Japan +8

A nationwide survey of combined central and peripheral demyelination in Japan

Hidenori Ogata, Dai Matsuse, Ryo Yamasaki et al. · Journal of Neurology Neurosurgery & Psychiatry · 2015 · 88 citations

Peripheral Demyelination, Neurological Disorder, Clinical Neurology +19

Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis

Makoto Hirotani, Masaaki Niino, Toshiyuki Fukazawa et al. · Journal of Neuroimmunology · 2010 · 77 citations · Full text

Inflammation, Cytokine, Autoimmune Disease +11